Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Restasis for Disease Progression in Dry Eye
NCT00567983Phase 4Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Dec 2007
- Primary completion
- Sep 2008
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of cyclosporine in dry eye disease (DED), sponsored by Janssen Pharmaceutical. Started Dec 2007; status: completed.
02
Drugs
cyclosporine
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT00567983.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00567983.